Rocket Pharmaceuticals, Inc. (RCKT)

3.73 -0.15 (-3.87%) USD  |  NASDAQ  |  Jan 09, 16:00
3.76 +0.03 (+0.80%) After-Hours: 20:00
More

Rocket Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for RCKT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
Merck & Co., Inc. Upgrade
Avalo Therapeutics, Inc. Upgrade
Artiva Biotherapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade